A study has shown that the activation of ERK 1/2 by TGF-β contributes to the progression of aortic aneurysm in murine model of Marfan syndrome, and that antagonists of this pathway may be therapeutically advantageous [29]. The gene discussed is TGFB1; the disease is Marfan syndrome.